Lifestyle changes could prevent 400 cardiac events and 200 deaths in Swedish PCI patients

August 28, 2012

Up to 400 cardiac events and 200 deaths in Swedish PCI patients could be avoided by following a heart healthy lifestyle, according to research from the SPICI study presented at ESC Congress 2012. The results were presented at ESC press conference by Professor Joep Perk from Linnaeus University and at the scientific session by Dr Roland CARLSSON.

The benefits of adherence to a heart in combination with drug treatment after an treated with coronary artery balloon intervention (PCI) have recently been examined. The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS-5) trial showed an up to four-fold reduction of new within six months after PCI among patients who followed lifestyle recommendations as compared to those who failed to do so.

The Study of Patient Information after (SPICI) investigated the possible gains of a heart healthy lifestyle in a large sample of Swedish patients after PCI (n=1073, 26% females, 74% males, average age 66 years). Within the first two months after PCI patients were asked to report on their current use of tobacco, physical activity and food habits.

The researchers found that although half of the previous smokers had quit, 16% still continued to use tobacco. Following nutritional guidance was reported by 55% but only 40% had changed their dietary habits. Approximately 50% were engaged in , mainly through training sessions in patient groups, but only 31% had actually increased their activity after PCI.

"A possible explanation may be the finding that many patients rated heredity and age as a more plausible cause of their disease than smoking, a lack of physical activity or poor ," said Professor Perk. "Furthermore, a majority reported that as a result of PCI they were cured from the underlying , thus adding to a lack of interest in changing lifestyle."

"Each year 18,000 patients undergo PCI in Sweden," he added. "Using the data from the OASIS-5 study we estimate the expected event rate in the Swedish population during the first half year after PCI to be more than 1,000 new cardiac events (, stroke and cardiovascular death)."

He continued: "If a 100% compliance to lifestyle recommendations could be reached among our patients instead of the less than satisfactory outcome in the present study there may be major health benefits: one third of the events in Sweden might be prevented annually. That equates to preventing 300 to 400 cardiac events, of which 150 to 200 would have resulted in death."

Professor Perk concluded: "Current practice after PCI in Sweden needs an in-depth revision. Greater emphasis on lifestyle factors and on methods to support a long-term commitment to behavioural change, are urgently needed."

Explore further: Long-term outcome similar with thrombus aspiration and stents in PCI

Related Stories

Long-term outcome similar with thrombus aspiration and stents in PCI

May 2, 2012
New research confirms thrombus aspiration (TA) during percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) provides long-term outcomes similar to conventional ...

CABG still preferred over PCI in patients with triple vessel disease

August 29, 2011
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary ...

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

June 22, 2011
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to ...

Results of the TRIGGER-PCI trial reported at TCT 2011

November 9, 2011
A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet reactivity (HCPR) following percutaneous coronary intervention (PCI) was ended early due to relatively few occurrences of ...

Angiotensin receptor blockers reduce no-reflow post-PCI

April 24, 2012
(HealthDay) -- For patients with acute myocardial infarction (AMI), pretreatment with angiotensin receptor blockers (ARBs) is linked with reduced incidence of the no-reflow phenomenon after percutaneous coronary intervention ...

Follow-up rehabilitation boosts survival odds for angioplasty patients

May 16, 2011
Patients who undergo a procedure to unblock a coronary artery are more likely to survive longer if they participate in structured follow-up care, according to research in Circulation: Journal of the American Heart Association.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.